These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30825056)

  • 21. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
    Sutherland A; Forsyth A; Cong Y; Grant L; Juan TH; Lee JK; Klimowicz A; Petrillo SK; Hu J; Chan A; Boutillon F; Goffin V; Egan C; Tang PA; Cai L; Morris D; Magliocco A; Shemanko CS
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic activity of lysophosphatidic acid in bone metastasis.
    Peyruchaud O; Leblanc R; David M
    Biochim Biophys Acta; 2013 Jan; 1831(1):99-104. PubMed ID: 22710393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
    Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
    Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro microenvironments to study breast cancer bone colonisation.
    Taubenberger AV
    Adv Drug Deliv Rev; 2014 Dec; 79-80():135-44. PubMed ID: 25453260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
    Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
    Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapies in bone metastasis.
    Clément-Demange L; Clézardin P
    Curr Opin Pharmacol; 2015 Jun; 22():79-86. PubMed ID: 25935860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acidosis Promotes Metastasis Formation by Enhancing Tumor Cell Motility.
    Riemann A; Schneider B; Gündel D; Stock C; Gekle M; Thews O
    Adv Exp Med Biol; 2016; 876():215-220. PubMed ID: 26782215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.
    Strazic-Geljic I; Guberovic I; Didak B; Schmid-Antomarchi H; Schmid-Alliana A; Boukhechba F; Bouler JM; Scimeca JC; Verron E
    Biochem Pharmacol; 2016 Sep; 116():11-21. PubMed ID: 27378505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapeutic targets for cancer bone metastasis.
    Krzeszinski JY; Wan Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
    Huang S; Tang Y; Peng X; Cai X; Wa Q; Ren D; Li Q; Luo J; Li L; Zou X; Huang S
    Oncol Rep; 2016 Oct; 36(4):2025-32. PubMed ID: 27498716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
    Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of osteolytic bone metastases.
    Guise TA
    Cancer; 2000 Jun; 88(12 Suppl):2892-8. PubMed ID: 10898330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
    Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
    Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
    Voorzanger-Rousselot N; Juillet F; Mareau E; Zimmermann J; Kalebic T; Garnero P
    Br J Cancer; 2006 Aug; 95(4):506-14. PubMed ID: 16880790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cell sequencing analysis reveals the relationship between tumor microenvironment cells and oxidative stress in breast cancer bone metastases.
    Zhang M; Chai X; Wang L; Mo K; Chen W; Xie X
    Aging (Albany NY); 2023 Jul; 15(14):6950-6968. PubMed ID: 37470685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation.
    Coenegrachts L; Maes C; Torrekens S; Van Looveren R; Mazzone M; Guise TA; Bouillon R; Stassen JM; Carmeliet P; Carmeliet G
    Cancer Res; 2010 Aug; 70(16):6537-47. PubMed ID: 20682798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The breast tumor microenvironment: role in cancer development, progression and response to therapy.
    Mittal S; Brown NJ; Holen I
    Expert Rev Mol Diagn; 2018 Mar; 18(3):227-243. PubMed ID: 29424261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.